Skip to main content
. Author manuscript; available in PMC: 2022 Oct 25.
Published in final edited form as: Int J Pharm. 2021 Sep 20;608:121095. doi: 10.1016/j.ijpharm.2021.121095

Figure 6.

Figure 6.

In vivo histological assessment of different liposomal nanoparticle formulations in C57BL/6 mice after 6 days post formulation administration. The figure depicts H&E stained tissue sections of Brain, Liver, Spleen, Kidney, Lungs, and Heart post administration of PBS (negative control) and different liposomal nanoparticles prepared in this study.